HE homepage

The U.S. Food and Drug Administration (FDA) has shared a new warning about ongoing safety issues with atherectomy devices sold and distributed by Bard Peripheral Vascular, an Arizona-based subsidiary of Becton, Dickinson and Company (BD). The warning includes multiple models of Bard Peripheral Vascular’s Rotarex Atherectomy System, which is designed to target high-risk plaques and blood clots in the peripheral arteries by rotating at a high speed.

More than 100 incidents have been reported so far. The FDA is still evaluating this issue, but the agency wanted to raise awareness as quickly as possible.

artificial intelligence AI in healthcare

People are still asking if AI will replace doctors or other healthcare workers. 

healthcare executives

Last summer more than 40% of 121 hospital executives surveyed said their organization had already realized a decent ROI in generative AI. However, a C-suite slice of nearly the same size said it was too soon to know for sure. 

U.S. Department of Health and Human Services (HHS) HQ

A spokesperson told HealthExec that "several types of external communications" are no longer subject to any pause, including urgent public health alerts. 

The Epic EMR booth at HIMSS 2023. Photo by Dave Fornell

KLAS Research announced the winners of its 2025 Best in KLAS awards this week, recognizing top performers across approximately 150 health informatics market segments.

There have been no injuries. However, due to the serious risk of death, the devices manufactured by Jiangsu Jumao X-Care Medical Equipment must be removed from the market immediately. 

Around the web

Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.